ReviewNanomaterials (Basel, Switzerland)2022
MXene-Based Ink Design for Printed Applications.
Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Mechanical Robustness and Conductivity Retention in TiACS omega · 2026Article
- MXene-Based Piezoelectric and Triboelectric Energy Harvesters for Personalized Monitoring and Therapeutics.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Recent Advances in MXene-Based Composites for Their Efficiency in the Degradation of Antibiotics and Water Splitting.Molecules (Basel, Switzerland) · 2025Review
- Nanocomposite Design for Energy-Related Applications.Nanomaterials (Basel, Switzerland) · 2025Article
- Influence of Surface Texture in Additively Manufactured Biocompatible Materials and Triboelectric Behavior.Materials (Basel, Switzerland) · 2025Review
- Recent Advances and Strategies in MXene-Based Electrodes for Supercapacitors: Applications, Challenges and Future Prospects.Nanomaterials (Basel, Switzerland) · 2023Review
- Current Trends and Promising Electrode Materials in Micro-Supercapacitor Printing.Materials (Basel, Switzerland) · 2023Review
- Stable MXene Dough with Ultrahigh Solid Fraction and Excellent Redispersibility toward Efficient Solution Processing and Industrialization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
- Wetting of MXenes and Beyond.Nano-micro letters · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MXenes are a class of two-dimensional nanomaterials with a rich chemistry, hydrophilic surface and mechano-ceramic nature, and have been employed in a wide variety of applications ranging from medical and sensing devises to electronics, supercapacitors, electromagnetic shielding, and environmental applications, to name a few. To date, the main focus has mostly been paid to studying the chemical and physical properties of MXenes and MXene-based hybrids, while relatively less attention has been paid to the optimal application forms of these materials. It has been frequently observed that MXenes show great potential as inks when dispersed in solution. The present paper aims to comprehensively review the recent knowledge about the properties, applications and future horizon of inks based on 2D MXene sheets. In terms of the layout of the current paper, 2D MXenes have briefly been presented and followed by introducing the formulation of MXene inks, the process of turning MAX to MXene, and ink compositions and preparations. The chemical, tribological and rheological properties have been deeply discussed with an eye to the recent developments of the MXene inks in energy, health and sensing applications. The review ends with a summary of research pitfalls, challenges, and future directions in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.